Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-05-17
2005-05-17
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S194000, C544S212000
Reexamination Certificate
active
06894047
ABSTRACT:
This invention is directed to sorbitol dehydrogenase inhibitory compounds of formula Iwherein R1, R2and R3are as defined in the specification. This invention is also directed to pharmaceutical compositions containing these compounds and to methods of treating or preventing diabetic complications, particularly diabetic neuropathy, diabetic nephropathy, diabetic microangiopathy, diabetic macroangiopathy, diabetic cardiomyopathy and foot ulcers. This invention is also directed to pharmaceutical compositions comprising a combination of a compound of formula I of the present invention with a second pharmaceutical agent, including an aldose reductase inhibitor, a sodium hydrogen ion exchange inhibitor, a glycogen phosphorylase inhibitor, a selective serotonin reuptake inhibitor, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, an angiotensin converting enzyme inhibitor, a thiazolidinedione antidiabetic agent, an angiotensin II receptor antagonist, a γ-aminobutyric acid agonist, a phosphodiesterase type 5 inhibitor, an adenosine agonist, and a CETP inhibitor and to methods of using these compositions.
REFERENCES:
patent: 3583986 (1971-06-01), Heimberger et al.
patent: 3703514 (1972-11-01), Aron-Samuel et al.
patent: 5138058 (1992-08-01), Geisen et al.
patent: 5215990 (1993-06-01), Geisen et al.
patent: 5728704 (1998-03-01), Mylari et al.
patent: 5866578 (1999-02-01), Mylari et al.
patent: 6414149 (2002-07-01), Chu-Moyer et al.
patent: 1041068 (2000-10-01), None
patent: WO0059510 (2000-10-01), None
Obrosova et al., Diabetologia, 42(10): 1187-1194.*
U.S. Non-provisional Appl. No. 09/997,039, filed Nov. 29, 2001.
U.S. Non-provisional Appl. No. 09/974,414, filed Oct. 9, 2001.
Roger L. N. Harris,The Synthesis of Triazines from N-Cyanoamidines, Synthesis, Communications, Oct. 1980, p. 841-842.
Balasubramanian Venkataraman
Benson Gregg C.
Gammill Martha A.
Pfizer Inc.
Richardson Peter C.
LandOfFree
Triazine compounds useful as sorbitol dehydrogenase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazine compounds useful as sorbitol dehydrogenase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazine compounds useful as sorbitol dehydrogenase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3379519